AI assistant
Microbot Medical Inc. — Director's Dealing 2012
May 17, 2012
33819_dirs_2012-05-16_96ee32d8-ca2f-4596-a026-483fed0f5d6c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2012-05-15
Reporting Person: TSUKAMOTO ANN (EVP, Research and Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-15 | Common Stock | F | 1089 | $0.85 | Disposed | 196101 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3643 | Indirect |
| Common Stock | 11245 | Indirect |
Footnotes
F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by her from the delivery of shares incident to the vesting of restricted stock units.
F2: Includes (1) 130,000 restricted stock units, with 43,333 vesting on each of January 27, 2013, January 27, 2014 and January 27, 2015; (2) 46,667 restricted stock units, with 23,333 vesting on each of June 1, 2012 and June 1, 2013; and (2) 2,333 restricted stock units vesting on May 15, 2013.
F3: 3,643 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership.
F4: Shares held in 401(k) account in accordance with issuer's employer-match policies.